Trial record 1 of 6 for:    Leber congenital amaurosis phase 3
Previous Study | Return to List | Next Study

Safety and Efficacy Study in Subjects With Leber Congenital Amaurosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2014 by Spark Therapeutics, LLC
Children's Hospital of Philadelphia
University of Iowa
Information provided by (Responsible Party):
Spark Therapeutics, LLC Identifier:
First received: October 21, 2009
Last updated: January 13, 2014
Last verified: January 2014